Monday, April 16, 2012

Worthington Law Firm to Support 2nd International Symposium on Lung-Sparing Therapies for Mesothelioma

Mesothelioma experts will gather on Saturday, May 12th 2012 at the Sheraton Delfina Hotel in Santa Monica, California for the 2nd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. Dr. Robert Cameron, Director of the UCLA Mesothelioma Comprehensive Research Program and Chief of Thoracic Surgery at the West Los Angeles VA Medical Center, will lead the symposium again this year. Dr. Cameron has been a leading proponent of the lung-sparing pleurectomy/decortication surgical procedure for nearly 20 years.

The distinguished faculty at this year’s meeting will include experts from Houston, San Francisco, New York and as far away as South Africa, with additional experts in a wide range of medical/scientific fields. The seminar, which offers continuing medical education credit, is primarily designed for physicians, but is also open to physicians-in-training, nurses, students, and mesothelioma patients, families and friends who want to learn more about the disease.

At the 1st International Symposium, specialists reviewed the Mesothelioma And Radical Surgery (MARS) trial from the UK and unanimously concluded that patients with mesothelioma no longer should be subjected to lung-removing surgery (EPP) and that more symposia should be held to discuss and promote lung-sparing therapies

"This symposium brings the best scientific and medical minds together to advance the treatment of mesothelioma," said Dr. Cameron. "Research and practice over the past several years have continued to evolve, working to improve cancer outcomes without unnecessarily sacrificing the affected lung. Clearly, it is best for the patient to treat mesothelioma as a chronic illness while preserving the function of both lungs."

The Worthington Law Firm is pleased to once again serve as a sponsor for this unique symposium which focuses on rational lung-sparing surgical and non-surgical therapies for treating pleural mesothelioma. The firm has donated $50,000 for this year’s symposium, matching its contribution of the same amount for last year’s first-ever symposium on lung sparing therapies. "A one-size fits all approach to mesothelioma simply hasn't worked," said Roger Worthington, who has been representing mesothelioma patients since 1989. "We applaud Dr. Cameron's efforts to invite the world's brightest doctors to take a fresh look at how to convert this nasty tumor into a chronic, treatable disease." 

Early Bird tickets to the symposium can be purchased before April 28th online at  or by calling UCLA’s Office of Continuing Medical Education (CME) at 310-794-2620.

For a copy of the seminar program, including the schedule, list of speakers and their bios, logistical information and the enrollment application and fees, please click here.

For more information, please contact CME or Clare Cameron at the Pacific Meso Center at the Pacific Heart, Lung, Blood Institute at 310-478-4678.

No comments:

Post a Comment